Skip to Content
Merck

Anaplastic large cell lymphomas: a study of 75 pediatric patients.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society (2007-05-31)
E S G d'Amore, A Menin, E Bonoldi, P Bevilacqua, S Cazzavillan, V Donofrio, C Gambini, M Forni, A Gentile, G Magro, R Boldrini, M Pillon, A Rosolen, R Alaggio
ABSTRACT

In this article, we describe the morphologic and immunophenotypic features of 75 cases of pediatric anaplastic large cell lymphoma (ALCL). According to the World Health Organization classification, 49 cases were common subtype ALCL, and respectively, 3, 6, and 17 cases were small cell, lymphohistiocytic, or mixed histologic variants. Anaplastic lymphoma kinase positivity was detected in 90.7% of the tumors and, using a panel of 9 T-cell surface markers, 88% could be assigned to the T-cell lineage. A molecular analysis for the T-cell receptor gamma (TCR- gamma) and the heavy chain of the immunoglobulin H rearrangements was performed on 6/9 ALCLs with a null immunophenotype, and a TCR clonal pattern was detected in 5/6 cases. In addition, 94.1% were immunoreactive for 1 or more cytotoxic proteins (Tia1, granzyme B, or perforin), and 15% expressed CD56. Clusterin, CD83, and Pax5, respectively, expressed in 91.3%, 1.7%, and 0% of the ALCLs, were useful biomarkers for the differential diagnosis with Hodgkin's lymphomas.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Perforin (MRQ-23) Mouse Monoclonal Antibody